Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / ABCL - AbCellera expands collaboration with Empirico on antibody discovery

ABCL - AbCellera expands collaboration with Empirico on antibody discovery

AbCellera Biologics Inc.
AbCellera (NASDAQ:ABCL) has expanded a collaboration with Empirico from five to seven targets to identify antibodies against them. Also, AbCellera now has a co-development option on a program-by-program basis. Financial terms of the expanded agreement were not disclosed. Empirico's Precision Insights Platform is designed to discover genetically validated drug targets, while AbCellera's (ABCL) technology identifies lead candidate antibodies against those targets. Read why Seeking Alpha contributor Confoundedinterest says that AbCellera (ABCL) is a strong buy.

For further details see:

AbCellera expands collaboration with Empirico on antibody discovery
Stock Information
Company Name: AbCellera Biologics Inc.
Stock Symbol: ABCL
Market: NASDAQ
Website: abcellera.com
Menu
ABCL ABCL Quote ABCL Short ABCL News ABCL Articles ABCL Message Board
Get ABCL Alerts

News, Short Squeeze, Breakout and More Instantly...